Our formulation laboratories are fully equipped to work on new chemical entities (NCE’s), generics, speciality products, reformulation and life cycle extension of existing molecules. We have the expertise for developing robust formulations for molecules that have solubility, bioavailability and stability concerns.

Aizant offers complete stability testing programs on pharmaceutically relevant compounds including API’s, pilot-formulation, packaging changes, drug development, customer manufactured products and clinical trial supplies. All storage conditions are validated and monitored and compliant to 21 CFR Part 11.

We provide manufacturing support for all your clinical supply needs from Phase I to Phase III studies. Preparation and coordination of Chemistry, Manufacturing and Controls (CMC) documentation for worldwide regulatory submissions.

This page is Under Construction

Aizant clinical research is capable of handling all types of bioavailability (BA)/ bioequivalence (BE) studies, in healthy human volunteers. As per international conference on harmonization (ICH) and good clinical practice (GCP) guidelines. The studies are accepted for submission to global regulatory agencies.

Strong scientific and regulatory knowledge combined with expertise and experienced scientists who understand your need for timely and accurate communication allows Aizant to offer extensive bioanalytical services from discovery through phase IV.

CLINIMINDS Collaborates With Aizant Drug Research Solutions Pvt. Ltd., Hyderabad For Clinical Research Education & Training Solutions.